8-K Announcements
6Material company update
May 8, 2026·SEC
Material company update
Apr 15, 2026·SEC
Material company update
Mar 31, 2026·SEC
LENSAR, Inc.(LNSR)Earnings, Financials & Key Ratios
LNSR•NASDAQ
$6.19
Price updated Jul 6, 2026
AboutLENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.Show more
- Revenue$58M+9.2%
- EBITDA-$20M-198.1%
- Net Income-$34M-9.2%
- EPS (Diluted)-2.87-5.1%
- Gross Margin46.41%-4.0%
- EBITDA Margin-34.36%-172.9%
- Operating Margin-42.06%-111.0%
- Net Margin-58.66%
LNSR Price & Volume
LENSAR, Inc. (LNSR) stock price & volume — 10-year historical chart
Loading chart...
Decelerating Growth Masks Persistent Operational Cash Burn
Investment Thesis • Updated 2026Q1
VerdictNegative: The company's inability to generate positive free cash flow
Growth:Decelerating
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Liquidity and capital runway
Key Thesis Takeaways
- LENSAR faces a challenging path to profitability as revenue growth has decelerated to a 5.2% contraction in 2026Q1, signaling potential saturation in the ALLY system's initial market adoption.
- The company's financial stability remains precarious, evidenced by an accumulated deficit of $141.2M and a history of volatile operating margins that reached -30.7% in 2025Q4.
- Investors should monitor the company's ability to manage its $12.5M cash position against ongoing capital-intensive requirements, as the current business model appears to necessitate further dilutive financing to sustain operations.
Verdict Logic
evidenced by a $4.3M outflow in 2026Q1, combined with a significant $141.2M accumulated deficit, suggests substantial risk of future shareholder dilution.
LNSR Growth Metrics
LENSAR, Inc. (LNSR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years17.24%
3 Years18.23%
TTM1.12%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM151.95%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM88.09%
Return on Capital
10 Years-38.54%
5 Years-34.67%
3 Years-34.42%
Last Year-59.84%
LNSR Recent Earnings
LENSAR, Inc. (LNSR) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 8, 2026Metric
Actual
Est
EPS
$2.99+1516.2%
$0.18
Rev
$13M-6.0%
$13M
Q2 2026
Mar 31, 2026Metric
Actual
Est
EPS
$0.12-80.7%
$0.07
Rev
$13M-37.6%
$20M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.31-210.0%
$0.10
Rev
$14M-29.5%
$20M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.15-87.5%
$0.08
Rev
$14M-21.5%
$18M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 8, 2026 | $2.99vs $0.18+1516.2% | $13Mvs $13M-6.0% |
| Q2 2026 | Mar 31, 2026 | $0.12vs $0.07-80.7% | $13Mvs $20M-37.6% |
| Q4 2025 | Nov 6, 2025 | $0.31vs $0.10-210.0% | $14Mvs $20M-29.5% |
| Q3 2025 | Aug 7, 2025 | $0.15vs $0.08-87.5% | $14Mvs $18M-21.5% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for LENSAR, Inc. (LNSR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $6.19 | $74.93M | -2.16 | 9.24% | -58.66% | — | — | |
| $17.32 | $1.97B | -14.20 | 8.28% | -25.66% | -50.82% | — | |
| $188.39 | $13.49B | 33.34 | 0.9% | 10.5% | 10.7% | — | |
| $32.39 | $1.64B | -134.96 | 14.88% | -0.83% | -0.95% | — | |
| $103.72 | $2.36B | 41.16 | 13.53% | 24.35% | 16.19% | — | |
| $45.24 | $2.06B | 1021.22 | 6.53% | 1.67% | 1.64% | — |
Compare LNSR vs Peers
LENSAR, Inc. (LNSR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
LNSR SEC Filings & Documents
LENSAR, Inc. (LNSR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when LNSR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
LNSR Frequently Asked Questions
LENSAR, Inc. (LNSR) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is LENSAR, Inc.'s revenue?
LENSAR, Inc. (LNSR) reported $57.7M in revenue for fiscal year 2025. This represents a 137% increase from $24.4M in 2018.
How fast is LENSAR, Inc. growing?
LENSAR, Inc. (LNSR) grew revenue by 9.2% over the past year. This is steady growth.
Is LNSR profitable?
Yes, LENSAR, Inc. (LNSR) is profitable, generating $29.4M in net income for fiscal year 2025 (-58.7% net margin).
Dividend & Returns
What is LENSAR, Inc.'s free cash flow?
LENSAR, Inc. (LNSR) had negative free cash flow of $12.2M in fiscal year 2025, likely due to heavy capital investments.